ArticleFrontiers in oncology2026
Case Report: Cerebrospinal fluid cytology as a diagnostic clue in hemorrhagic glioblastoma mimicking hypertensive intracranial hemorrhage.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glioblastoma (GBM) rarely presents with spontaneous intracerebral hemorrhage (ICH) as the initial symptom. A massive hematoma can completely obscure the underlying tumor on imaging, leading to misdiagnosis and treatment delay. Cerebrospinal fluid (CSF) cytology is simple and inexpensive, but is underutilized in the diagnostic workup of atypical ICH. Case presentation: A 60-year-old man with poorly controlled hypertension presented with sudden left-sided weakness and vomiting. CT showed a large right basal ganglia hemorrhage (87.1 mL, 72.8 HU) with a midline shift of 17.8 mm. After endoscopic hematoma evacuation, hypertensive ICH was diagnosed. However, two months after discharge, the patient was readmitted with bone-flap bulging and elevated intracranial pressure. Follow-up MRI showed only a cystic lesion, interpreted as postoperative or inflammatory change. Lumbar puncture was performed for CSF cytology. Three consecutive punctures all revealed numerous atypical cells with high nuclear-to-cytoplasmic ratios, pseudopod-like protrusions, and atypical mitotic figures. CSF biochemistry showed markedly elevated protein (7.03 g/L) and decreased glucose (0.9 mmol/L). Pathology later confirmed IDH1-wildtype glioblastoma (WHO grade IV) with leptomeningeal spread. Conclusion: When a large hematoma masks an underlying tumor on imaging and atypical imaging features or abnormal clinical recovery are present, CSF cytology can provide a crucial diagnostic clue. This case highlights that CSF cytology should be actively pursued in patients with atypical ICH, especially when follow-up imaging shows only non-specific changes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.